Resveratrol induces apoptosis of bladder cancer cells via miR‑21 regulation of the Akt/Bcl‑2 signaling pathway

Zhou,Chenxi; Ding,Jun; Wu,Yuanwen

doi:10.3892/mmr.2014.1950

Resveratrol induces apoptosis of bladder cancer cells via miR‑21 regulation of the Akt/Bcl‑2 signaling pathway

Authors:
- Chenxi Zhou
- Jun Ding
- Yuanwen Wu
View Affiliations

Affiliations: Department of Urology, Taihu Hospital, 101st Hospital of PLA, Wuxi, Jiangsu 214044, P.R. China
Published online on: February 13, 2014 https://doi.org/10.3892/mmr.2014.1950
Pages: 1467-1473

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Resveratrol, an edible polyphenolic phytoalexin present in grapes and red wine, has been reported to inhibit proliferation and induce apoptosis of bladder cancer cells. In the present study, the molecular mechanisms of resveratrol on human bladder cancer cell apoptosis was examined. The effect of resveratrol on the viability and apoptosis of T24 and 5637 cells was measured using an MTT assay and flow cytometric analysis, respectively. Next, the effect of resveratrol on miR‑21 expression was detected by real‑time PCR. The expression of phospho‑Akt and Bcl‑2 following treatment with resveratrol or the downregulation of miR‑21 expression were also measured. Resveratrol induced the cytotoxicity and apoptosis of T24 and 5637 cells in a dose‑dependent manner. Resveratrol decreased the expression of miR‑21, the level of phospho‑Akt and Bcl‑2 protein expression. In addition, the downregulation of miR‑21 expression inhibited the level of phospho‑Akt and Bcl‑2 expression. Insulin‑like growth factor‑1 was able to reverse the effect of the miR‑21 inhibitor on Bcl‑2 expression and apoptosis in T24 and 5637 cells. Notably, overexpression of miR‑21 expression was able to restore the inhibition of Akt activity, downregulation of Bcl‑2 expression and apoptosis induced by resveratrol. Collectively, data revealed that the effect of resveratrol on bladder cancer cell apoptosis was due to miR‑21 regulation of the Akt/Bcl‑2 signaling pathway.

View Figures

View References

1	Kirkali Z, Chan T, Manoharan M, Algaba F, et al: Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology. 66:4–34. 2005. View Article : Google Scholar : PubMed/NCBI
2	Lei AQ, Cheng L and Pan CX: Current treatment of metastatic bladder cancer and future directions. Expert Rev Anticancer Ther. 11:1851–1862. 2011. View Article : Google Scholar : PubMed/NCBI
3	Borriello A, Cucciolla V, Della Raqione F and Galletti P: Dietary polyphenols: Focus on resveratrol, a promising agent in the prevention of cardiovascular diseases and control of glucose homeostasis. Nutr Metab Cardiovasc Dis. 20:618–625. 2010. View Article : Google Scholar : PubMed/NCBI
4	Albani D, Polito L and Forloni G: Sirtuins as novel targets for Alzheimer’s disease and other neurodegenerative disorders: experimental and genetic evidence. J Alzheimers Dis. 19:11–26. 2010.
5	Harikumar KB and Aggarwal BB: Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle. 7:1020–1035. 2008. View Article : Google Scholar : PubMed/NCBI
6	Lin X, Wu G, Huo WQ, Zhang Y and Jin FS: Resveratrol induces apoptosis associated with mitochondrial dysfunction in bladder carcinoma cells. Int J Urol. 19:757–764. 2012. View Article : Google Scholar : PubMed/NCBI
7	Bai Y, Mao QQ, Qin J, Zheng XY, Wang YB, Yang K, Shen HF and Xie LP: Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo. Cancer Sci. 101:488–493. 2010. View Article : Google Scholar : PubMed/NCBI
8	Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
9	Winter J, Jung S, Keller S, Gregory RI and Diederich S: Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol. 11:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
10	Si ML, Zhu S, Wu H, Lu Z, Wu F and Mo YY: miR-21-mediated tumor growth. Oncogene. 26:2799–2803. 2007. View Article : Google Scholar : PubMed/NCBI
11	Link A, Becker V, Goel A, Wex T and Malfertheiner P: Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancer. PLoS One. 7:e429332012. View Article : Google Scholar : PubMed/NCBI
12	Buscaglia LE and Li Y: Apoptosis and the target genes of microRNA-21. Chin J Cancer. 30:371–380. 2011. View Article : Google Scholar : PubMed/NCBI
13	Tili E, Michaille JJ, Alder H, Volinia S, Delmas D, Latruffe N and Croce CM: Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFβ signaling pathway in SW480 cells. Biochem Pharmacol. 80:2057–2065. 2010.PubMed/NCBI
14	Liu P, Liang H, Xia Q, Li P, Kong H, Lei P, Wang S and Tu Z: Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression. Clin Transl Oncol. 15:741–746. 2013. View Article : Google Scholar : PubMed/NCBI
15	Tao J, Lu Q, Wu D, Li P, Xu B, Qing W, Wang M, Zhang Z and Zhang W: microRNA-21 modulates cell proliferation and sensitivity to doxorubicin in bladder cancer cells. Oncol Rep. 25:1721–1729. 2011.PubMed/NCBI
16	Ching CB and Hansel DE: Expanding therapeutic targets in bladder cancer: the PI3K/Akt/mTOR pathway. Lab Invest. 90:1406–1414. 2010. View Article : Google Scholar : PubMed/NCBI
17	Oka N, Tanimoto S, Taue R, Nakatsuji H, Kishimoto T, Izaki H, Fukumori T, Takahashi M, Nishitani M and Kanayama HO: Role of phosphatidylinositol-3 kinase/Akt pathway in bladder cancer cell apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand. Cancer Sci. 97:1093–1098. 2006. View Article : Google Scholar : PubMed/NCBI
18	Pietenpol JA, Paradopoulos N, Markowitz S, Willson JK, Kinzler KW and Vogelstein B: Paradoxical inhibition of solid tumor cell growth by bcl2. Cancer Res. 54:3714–3717. 1994.PubMed/NCBI
19	Kunze D, Wuttig D, Fuessel S, Kraemer K, Kotzsch M, Meye A, Grimm MO, Hakenberg OW and Wirth MP: Multitarget siRNA inhibition of antiapoptotic genes (XIAP, BCL2, BCL-XL) in bladder cancer cells. Anticancer Res. 28:2259–2263. 2008.PubMed/NCBI
20	Riedl SJ and Shi Y: Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol. 5:897–907. 2004. View Article : Google Scholar : PubMed/NCBI
21	Jung JI, Cho HJ, Kim J, Kwon DY and Park JH: trans-10, cis-12 conjugated linoleic acid inhibits insulin-like growth factor-I receptor signaling in TSU-Pr1 human bladder cancer cells. J Med Food. 13:13–19. 2010. View Article : Google Scholar : PubMed/NCBI
22	Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, et al: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 275:218–220. 1997. View Article : Google Scholar : PubMed/NCBI
23	Baur JA and Sinclair DA: Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 5:493–506. 2006. View Article : Google Scholar : PubMed/NCBI
24	Wang YB, Qin J, Zheng XY, Bai Y, Yang K and Xie LP: Diallyl trisulfide induces Bcl-2 and caspase-3-dependent apoptosis via downregulation of Akt phosphorylation in human T24 bladder cancer cells. Phytomedicine. 17:363–368. 2010. View Article : Google Scholar : PubMed/NCBI
25	Shahjee HM, Koch KR, Guo L, Zhang CO and Keay SK: Antiproliferative factor decreases Akt phosphorylation and alters gene expression via CKAP4 in T24 bladder carcinoma cells. J Exp Clin Cancer Res. 29:1602010. View Article : Google Scholar : PubMed/NCBI